Beam Therapeutics Growth, Revenue, Number of Employees and Funding

Overview

Location:
Boston, MA USA
Total Funding:$222M
Industry:Biotech
Founded:2017
Lead Investor(s):Muliteple
Press

City Ranking

Industry Ranking

State Ranking

Growjo 10k Ranking

Estimated Revenue & Financials

  • Beam Therapeutics's estimated revenue is currently $16.4M per year.
  • Beam Therapeutics received $135.0M in venture funding in March 2019.
  • Beam Therapeutics's estimated revenue per employee is $145398
  • Beam Therapeutics's total funding is $222M.

Employee Data

  • Beam Therapeutics has 113 Employees.
  • Beam Therapeutics grew their employee count by 163% last year.
  • Beam Therapeutics currently has 4 job openings.

Executive Contacts

NameTitle
Francine GregoireVP Liver Diseases
Delai ChenAssociate Director, Nanoparticle formulation
Dana LevasseurVice President, Hematology
Courtney WallaceSVP/Head of Business Development and Strategy
Stephen CavnarDirector, New Product Planning
Susan O'ConnorChief Human Resources Officer
Matt LeeAssociate Director, Structural Biology & Protein Sciences
Charlie LiuDirector, Business Development & Operations
Brian BusserSenior Director
Carlo ZambonelliAssociate Director of Analytical Development

What Is Beam Therapeutics?

Beam Therapeutics is developing precision genetic medicines for serious diseases. Co-founded by scientific pioneers known for advancing CRISPR gene editing, were the first company to pursue development of new therapies using CRISPR base editing technology. We aim to use these technologies to generate a broad pipeline of precision genetic medicines that repair disease-causing point mutations, write in protective genetic variations, or modulate the expression or function of disease-causing genes. WHO WE ARE Beam is creating precision genetic medicines through base editing WHY WE DO IT Our dream is to provide life-long cures for patients suffering from serious diseases WHO WE ARE AND HOW WE WORK TOGETHER The Beam Team: A community of fearless innovators Rigorous and honest in our research Listening with open minds Committed to each other

keywords:N/A

113

Number of Employees

$16.4M

Revenue (est)

4

Current Jobs

163%

Employee Growth %

$222M

Total Funding

N/A

Valuation

N/A

Accelerator

N/A

Type

Similar Companies

NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
Ohana Bioscienc...
$6.7M4659%
Tango Therapeut...
$8.4M5841%$55M
Compass Therape...
$14.7M10215%
Hamilton Storag...
$13.6M949%
Alnylam Pharmac...
$74.9M122831%$417.5M
Axcella
$8.2M5719%
Berkshire Corpo...
$10.7M7412%
Repligen Corpor...
$47M32422%$242.6M
Allena Pharmace...
$6M5019%$93M
ABclonal Techno...
$7.9M5531%

Beam Therapeutics News

09/03/2019 - Beam Therapeutics Appoints Financial Industry Veteran, Terry-Ann Burrell, as Chief Financial Officer

CAMBRIDGE, Mass.--(BUSINESS WIRE)--. Beam Therapeutics, a biotechnology company developing precision genetic medicines through ...

09/08/2019 - Chutes & Ladders—Bausch Health's Salix loses McKenna to ...

LeSauteur comes out of the Human Health Therapeutics Research Center ... Cambridge, Massachusetts-based Beam Therapeutics has named ...

09/03/2019 - Growth of biopharma employment in Massachusetts

This year, Beam Therapeutics has been the largest beneficiary of venture capital, after raising $135m in its Series B financing round. However ...

Beam Therapeutics Funding

DateAmountRoundLead InvestorsReference
2018-05-15$87.0MAF-Prime Capital PartnersArticle
2019-03-07$135.0MBMulitepleArticle